Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1423053 MIAMI, FL
Back to MRVI Full portfolio

Position in MRVI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,245,011
+$9,044,390 QoQ
Shares Held
2,122,598
+43.0% QoQ
Ownership
0.817%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRVI Over Time

Shares Held

Position Value (USD)

Derivatives in MRVI

reported options exposure · as of Jun 30, 2026
CallValue
$165,360
CallShares
26,500
PutValue
$244,608
PutShares
39,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. MRVI ranks #81 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in MRVI

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $165,360 26,500
2026-06-30 $13,245,011 2,122,598
2026-06-30 $244,608 39,200
2026-03-31 $215,080 76,000
2026-03-31 $135,557 47,900
2026-03-31 $4,200,621 1,484,319
2025-12-31 $41,275 12,700
2025-12-31 $2,006,725 617,454
2025-12-31 $489,775 150,700
2025-09-30 $255,010 88,854
2025-09-30 $33,292 11,600
2025-09-30 $449,442 156,600
2025-06-30 $299,563 124,300
2025-06-30 $1,467,058 608,738
2025-06-30 $30,125 12,500
2025-03-31 $97,240 44,000
2025-03-31 $2,362,041 1,068,797
2025-03-31 $28,067 12,700
2024-12-31 $329,725 60,500
2024-12-31 $109,545 20,100
2024-12-31 $114,281 20,969
2024-09-30 $324,921 39,100
2024-09-30 $44,043 5,300
2024-06-30 $2,560,050 357,549
2024-06-30 $15,752 2,200
2024-06-30 $156,088 21,800
2024-03-31 $195,942 22,600
2024-03-31 $2,342,313 270,163
2024-03-31 $128,316 14,800
2023-12-31 $3,275 500
2023-12-31 $1,310 200
2023-12-31 $7,504,216 1,145,682
2023-09-30 $29,000 2,900
2023-09-30 $37,000 3,700
2023-09-30 $17,621,300 1,762,130
2023-06-30 $203,305 16,356
2023-06-30 $63,393 5,100
2023-06-30 $268,488 21,600
2023-03-31 $526,776 37,600
2023-03-31 $50,436 3,600
2023-03-31 $7,293,003 520,557
2022-12-31 $7,101,795 496,282
2022-12-31 $238,977 16,700
2022-12-31 $465,075 32,500
2022-09-30 $505,494 19,800
2022-09-30 $1,455,210 57,000
2022-09-30 $46,570,932 1,824,165
2022-06-30 $3,869,696 136,209
2022-06-30 $838,095 29,500
2022-06-30 $2,684,745 94,500

Report a Problem

Category
Description
Email (optional, for follow-up)